<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182022000200006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Antígenos del sistema ABO y manifestaciones clínicas de la Covid-19 en un área de salud del municipio Bayamo]]></article-title>
<article-title xml:lang="en"><![CDATA[Antigens of the ABO system and clinical manifestations of Covid-19 in a health area of &#8203;&#8203;the Bayamo municipality]]></article-title>
<article-title xml:lang="pt"><![CDATA[Antígeno do sistema ABO e manifestações clínicas do Covid-19 em uma área de saúde do município de Bayamo]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cruz Manzano]]></surname>
<given-names><![CDATA[Elio Felipe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández González]]></surname>
<given-names><![CDATA[Juan Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fonseca González]]></surname>
<given-names><![CDATA[Ramón Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sarduy Rodríguez]]></surname>
<given-names><![CDATA[Ariel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Milanés Ojeada]]></surname>
<given-names><![CDATA[María Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Facultad de Ciencias Médicas Bayamo ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182022000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182022000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182022000200006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: se han descrito una plétora de síntomas/signos que indican claramente que la COVID-19 es una enfermedad compleja, y un número creciente de reportes han sugerido que los grupos sanguíneos ABO están relacionados con el riesgo a desarrollar la enfermedad.  Objetivo: identificar si existe relación entre los fenotipos sanguíneos del sistema ABO y las manifestaciones clínicas de la Covid-19 en un área de salud del municipio Bayamo.  Métodos: se realizó un estudio descriptivo retrospectivo, que incluyó a 123 pacientes confirmados de COVID-19 con alta epidemiológica. Se determinó el grupo sanguíneo según el sistema ABO. Los sujetos fueron clasificados según el número de síntomas/signos, el predominio de síntomas/signos respiratorios o no. Se analizó la asociación entre los grupos sanguíneos del sistema ABO, los portadores de los diferentes antígenos en comparación con las de aquellos sin el antígeno y los grupos por número de síntomas y signos, y según predominio o no de síntomas/signos respiratorios.  Resultados: se encontró una asociación significativa entre el grupo sanguíneo de los pacientes y los grupos según el número de síntomas/signos presentados, así como, entre los portadores de antígenos B y no B y los grupos según el número de síntomas/signos presentados y el predominio de los síntomas respiratorios o no, en todos los casos con una mayor frecuencia de pacientes con el fenotipo A.  Conclusiones: se concluye que en este estudio el grupo sanguíneo de los pacientes positivos a la Covid-19 se relacionó con el número de síntomas/signos presentados, con predominio de la frecuencia de portadores del antígeno A sobre los demás.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: A plethora of symptoms/signs have been described that clearly indicate that COVID-19 is a complex disease, and a growing number of reports have suggested that ABO blood groups are related to the risk of developing the disease.  Objective:  to identify if there is a relationship between the blood phenotypes of the ABO system and the clinical manifestations of Covid-19 in a health area in the Bayamo municipality.  Methods: a retrospective descriptive study was carried out, which included 123 confirmed COVID-19 patients with epidemiological discharge. Blood group was determined according to the ABO system. The subjects were classified according to the number of symptoms/signs, the predominance of respiratory symptoms/signs or not. The association between the blood groups of the ABO system, the carriers of the different antigens in comparison with those of those without the antigen and the groups by number of symptoms and signs, and according to predominance or not of respiratory symptoms/signs was analyzed.  Results: a significant association was found between the blood group of the patients and the groups according to the number of symptoms/signs presented, as well as between carriers of B and non-B antigens and the groups according to the number of symptoms/signs presented and the predominance of respiratory symptoms or not, in all cases with a higher frequency of patients with phenotype A.  Conclusions: it is concluded that in this study the blood group of patients positive for Covid-19 was related to the number of symptoms/signs presented, with a predominance of the frequency of carriers of antigen A over the others.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  foi descrita uma infinidade de sintomas/sinais que indicam claramente que a COVID-19 é uma doença complexa, e um número crescente de relatos sugere que os grupos sanguíneos ABO estão relacionados ao risco de desenvolver a doença.  Objetivo:  identificar se existe relação entre os fenótipos sanguíneos do sistema ABO e as manifestações clínicas da Covid-19 em uma área de saúde do município de Bayamo.  Métodos:  foi realizado um estudo descritivo retrospectivo, que incluiu 123 pacientes confirmados com COVID-19 com alta epidemiológica. O grupo sanguíneo foi determinado de acordo com o sistema ABO. Os sujeitos foram classificados de acordo com o número de sintomas/sinais, a predominância de sintomas/sinais respiratórios ou não. Foi analisada a associação entre os grupos sanguíneos do sistema ABO, os portadores dos diferentes antígenos em comparação com aqueles sem o antígeno e os grupos por número de sintomas e sinais, e segundo predominância ou não de sintomas/sinais respiratórios.  Resultados:  foi encontrada associação significativa entre o grupo sanguíneo dos pacientes e os grupos de acordo com o número de sintomas/sinais apresentados, bem como entre os portadores de antígenos B e não-B e os grupos de acordo com o número de sintomas/sinais apresentou e a predominância de sintomas respiratórios ou não, em todos os casos com maior frequência de pacientes com fenótipo A.  Conclusões:  conclui-se que neste estudo o grupo sanguíneo dos pacientes positivos para Covid-19 esteve relacionado ao número de sintomas/sinais apresentados, com predomínio da frequência de portadores do antígeno A sobre os demais.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="es"><![CDATA[Grupos sanguíneos ABO]]></kwd>
<kwd lng="es"><![CDATA[Antígenos A, B y O]]></kwd>
<kwd lng="es"><![CDATA[Síntomas/signos]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="en"><![CDATA[ABO blood groups]]></kwd>
<kwd lng="en"><![CDATA[Antigens A, B and O]]></kwd>
<kwd lng="en"><![CDATA[Symptoms / signs]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="pt"><![CDATA[Grupos sanguíneos ABO]]></kwd>
<kwd lng="pt"><![CDATA[Antígenos A, B e O]]></kwd>
<kwd lng="pt"><![CDATA[Sintomas/sinais]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Abreu]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Tejeda]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dieguez Guach]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínico-epidemiológicas de la COVID-19]]></article-title>
<source><![CDATA[Rev haban cienc méd]]></source>
<year>2020</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roblejo Balbuena]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez Cordero]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Gavilán]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo Ramírez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira Roche]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[García Gómez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínico-epidemiológicas de pacientes cubanos residentes en La Habana afectados por la COVID-19]]></article-title>
<source><![CDATA[Rev Cubana Investig Bio]]></source>
<year>2021</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<source><![CDATA[Dashboard Cuba: Covid19cubadata]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romo Domínguez]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Saucedo Rodríguez]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Hinojosa Maya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mercado Rodríguez]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Uc Rosaldo]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa García]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestaciones clínicas de la COVID-19]]></article-title>
<source><![CDATA[Rev Latin Infect Pediatr]]></source>
<year>2020</year>
<volume>33</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>s10-32</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Botrán]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asociación del grupo sanguíneo ABO con susceptibilidad a COVID-19]]></article-title>
<source><![CDATA[Ciencia, Tecnología y Salud]]></source>
<year>2020</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>325-32</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peña García]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez Padilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arruebarrena Blanco]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de casos positivos y sospechosos de COVID-19 con comorbilidades]]></article-title>
<source><![CDATA[Revista Finlay]]></source>
<year>2020</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>314-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Garner]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Salehi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[La Rocca]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Duncan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms a literature review of 23 studies]]></article-title>
<source><![CDATA[Annals of Hematology]]></source>
<year>2021</year>
<volume>100</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1123_32</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pendu]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Breiman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rocher]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dion]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruvoën Clouet]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data]]></article-title>
<source><![CDATA[Viruses]]></source>
<year>2021</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>160-80</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan]]></article-title>
<source><![CDATA[Front Cell Infect Microbial]]></source>
<year>2020</year>
<volume>10</volume>
<page-range>404</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Madhavan]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Sehga]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Nair]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mahajan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sehrawat]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extrapulmonary manifestations of COVID-19]]></article-title>
<source><![CDATA[Nat Med]]></source>
<year>2020</year>
<volume>26</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1017-32</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deleers]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Breiman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Daubie]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Maggetto]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Barreau]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Besse]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Covid-19 and blood groups ABO antibody levels may also matter.]]></article-title>
<source><![CDATA[Int. J. Infect. Dis]]></source>
<year>2021</year>
<volume>104</volume>
<page-range>250-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sebastian Kamps]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[COVID Reference]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Hamburg ]]></publisher-loc>
<publisher-name><![CDATA[Steinhäuser Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Government of Canada</collab>
<source><![CDATA[Coronavirus disease (COVID-19). COVID-19 signs, symptoms and severity of disease: A clinician guide.]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Canadad ]]></publisher-loc>
<publisher-name><![CDATA[Government of Canada]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>National Institutes of Health</collab>
<source><![CDATA[COVID-19 Treatment Guidelines. Clinical Spectrum of SARS-CoV-2 Infection]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Estados Unidos ]]></publisher-loc>
<publisher-name><![CDATA[NIH]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<collab>Juventud Rebelde</collab>
<article-title xml:lang=""><![CDATA[La herencia roja. Sección Opinión]]></article-title>
<source><![CDATA[Juventud Rebelde]]></source>
<year>1/08</year>
<month>/2</month>
<day>00</day>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nalbant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aydin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yaylaci]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kaya]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Wermeulen]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Cinemre]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of ABO blood group and age with COVID-19 positive test]]></article-title>
<source><![CDATA[Rev Assoc Med Bras]]></source>
<year>2021</year>
<volume>67</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>46-50</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dzik]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Eliason]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Morris]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufman]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[North]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 and ABO blood groups]]></article-title>
<source><![CDATA[Transfusion]]></source>
<year>2020</year>
<volume>60</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1883-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cai]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Deng]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between ABO blood groups and risk of SARS-CoV-2 pneumonia]]></article-title>
<source><![CDATA[Brit J Haematol]]></source>
<year>2020</year>
<volume>190</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-7</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva Filho]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Farias de Melo]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Lima de Oliveira]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions]]></article-title>
<source><![CDATA[Med Hypotheses]]></source>
<year>2020</year>
<volume>144</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gérard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Maggipinto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Minon]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 and ABO blood group: another viewpoint]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2020</year>
<volume>190</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e93-e4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
